Expression screening of 17q12–21 amplicon reveals GRB7 as an ERBB2-dependent oncogene
► We established an integrated analysis system of amplicons. ► Applying this system to 17q12–21 amplicon, we identified GRB7 as an ERBB2-dependent oncogene. ► GRB7 modulates the ERBB2 signaling pathway through enhanced phosphorylation of ERBB2 and Akt. ► BPS domain of GRB7 suppresses, while, the oth...
Saved in:
Published in: | FEBS letters Vol. 586; no. 12; pp. 1708 - 1714 |
---|---|
Main Authors: | , , , , , , , , , , , , , , , , , , , |
Format: | Journal Article |
Language: | English |
Published: |
England
Elsevier B.V
12-06-2012
|
Subjects: | |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Summary: | ► We established an integrated analysis system of amplicons. ► Applying this system to 17q12–21 amplicon, we identified GRB7 as an ERBB2-dependent oncogene. ► GRB7 modulates the ERBB2 signaling pathway through enhanced phosphorylation of ERBB2 and Akt. ► BPS domain of GRB7 suppresses, while, the other domains are required for GRB7-mediated transforming activity.
Gene amplification is a major genetic alteration in human cancers. Amplicons, amplified genomic regions, are believed to contain “driver” genes responsible for tumorigenesis. However, the significance of co-amplified genes has not been extensively studied. We have established an integrated analysis system of amplicons using retrovirus-mediated gene transfer coupled with a human full-length cDNA set. Applying this system to 17q12–21 amplicon observed in breast cancer, we identified GRB7 as a context-dependent oncogene, which modulates the ERBB2 signaling pathway through enhanced phosphorylation of ERBB2 and Akt. Our work provides an insight into the biological significance of gene amplification in human cancers. |
---|---|
Bibliography: | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 |
ISSN: | 0014-5793 1873-3468 |
DOI: | 10.1016/j.febslet.2012.05.003 |